Form 10-Q · Quarterly report
Mastercard 10-Q, filed Jul 30, 2026
- Filed
- CIK
- 0001141391
- Accession no.
- 0001141391-26-000083
Summary
Mastercard declared quarterly cash dividends of $0.87 per share payable in 2026 and repurchased $8.933 billion of its Class A common stock in the first half of 2026, leaving $8.528 billion of buyback authorization as of June 30, 2026. Mastercard also said its disclosure controls and procedures were effective and that its foreign-exchange and interest-rate risk exposures were limited.
Key points
- Mastercard's board declared dividends of $0.87 per share payable in February, May, and August 2026.
- Mastercard repurchased $8.933 billion of Class A common stock in the six months ended June 30, 2026, at an average price of $508.11 per share.
- Remaining share repurchase authorization was $8.528 billion at June 30, 2026, and $697 million more was repurchased from July 1 through July 27, 2026.
- Mastercard officers and directors including Linda Kirkpatrick, Sachin Mehra, and Julius Genachowski adopted Rule 10b5-1 trading arrangements in the second quarter of 2026.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Dividends and Share Repurchases We have historically paid quarterly dividends on our outstanding Class A common stock and Class B common stock. Subject to legally available funds, we intend to continue to pay a quarterly cash dividend. The declaration and payment of future dividends is at the sole discretion of our Board of Directors after taking into account various factors, including our financial condition, operating results, available cash and current and anticipated cash needs. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.